指南与共识冠心病外科瓣膜外科心外重症与机械循环支持

2026 AATS专家共识:心脏手术患者肝素诱导性血小板减少症的诊断与管理

2026 American Association for Thoracic Surgery Expert Consensus Document: Diagnosis and management of heparin-induced thrombocytopenia in patients who undergo cardiac surgery.
指南 / 共识 · J Thorac Cardiovasc Surg · 2026-05-04

该共识由美国胸外科协会临床实践标准委员会组织16名多学科专家制定,采用改良Delphi法,围绕心脏手术后HIT的流行病学、诊断评估、非肝素抗凝治疗、围术期管理及ECMO/临时机械循环支持患者的筛查与抗凝策略,共达成32条推荐。

要点

  • 心脏手术患者HIT诊断需结合4Ts评分、血小板计数时间模式及免疫学与功能学检测。
  • 治疗推荐使用非肝素抗凝药,包括直接凝血酶抑制剂和Xa因子抑制剂。
  • 需再次手术者应规划手术时机、术中抗凝策略及辅助治疗。

核心结论

  • 共识为心脏手术全程HIT诊断与管理提供实用指导,旨在提高诊断准确性、标准化诊疗并减少并发症。

研究设计与样本

  • 美国胸外科协会临床实践标准委员会召集16名心脏外科、血液学、重症、麻醉、灌注和药理学专家,经文献综述后采用改良Delphi法制订推荐。

主要发现

  • 共识在5个领域达成32条推荐,涵盖流行病学与自然史、诊断评估、非肝素抗凝治疗、围术期管理及ECMO/临时机械循环支持患者的筛查与抗凝。
  • 另含HIT患者体外循环回路管理的最佳实践。

关键数值与推荐

  • 诊断评估推荐包括适当使用4Ts评分、时间依赖性血小板计数模式及免疫学与功能学检测的整合。
  • 治疗推荐非肝素抗凝药,包括直接凝血酶抑制剂和Xa因子抑制剂的选择及辅助治疗。
  • 围术期管理推荐涵盖手术时机、术中抗凝策略及辅助治疗。

临床怎么用

  • 心脏手术患者应结合4Ts评分与血小板计数时间模式评估HIT风险,并整合免疫学与功能学检测明确诊断。
  • 确诊或高度疑似HIT时使用非肝素抗凝药,需再次手术者应提前规划手术时机与术中抗凝策略。
  • ECMO或临时机械循环支持患者应按共识推荐进行筛查、检测与抗凝管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin-induced thrombocytopenia (HIT) in patients who undergo cardiac surgery presents unique diagnostic and management challenges due to universal perioperative heparin exposure, postoperative platelet kinetics, and the high prevalence of critical illness in this population. Current guidelines do not fully address these cardiac surgery-specific features, leading to practice variation in screening, diagnosis, anticoagulation management, and perioperative planning. Consolidated, practical, and evidence-based recommendations are needed that are tailored to cardiac surgery and to temporary mechanical circulatory support after cardiac surgery. METHODS: The American Association for Thoracic Surgery Clinical Practice Standards Committee convened a multidisciplinary panel of 16 experts in cardiac surgery, hematology, critical care, anesthesiology, perfusion, and pharmacology. A comprehensive literature review was performed with medical librarian support. Using a modified Delphi methodology, the panel evaluated the evidence, developed clinical statements, and assigned a class of recommendation and a level of evidence to each recommendation. RESULTS: Consensus was achieved for 32 recommendations across 5 domains: epidemiology and natural history of HIT after cardiac surgery; diagnostic evaluation, including appropriate Thrombocytopenia, Timing, Thrombosis, oTher cause (4Ts) score use, time-dependent platelet count patterns, and integration of immunoassay and functional testing; therapeutic management with nonheparin anticoagulants, including the selection of direct thrombin inhibitors, factor Xa inhibitors, and adjunctive therapies; perioperative management of patients with HIT who require cardiac surgery, including the timing of surgery, intraoperative anticoagulation strategy, and adjunctive therapies; and screening, testing, and anticoagulation strategies for patients supported by extracorporeal membrane oxygenation or temporary mechanical circulatory support after cardiac surgery. Additional best practices are included for cardiopulmonary bypass circuit management for patients with HIT. CONCLUSIONS: This American Association for Thoracic Surgery Expert Consensus Document provides practical, cardiac surgery-specific guidance for the diagnosis and management of HIT across the continuum of cardiac surgical care. By addressing the complexities unique to cardiac surgery, high-risk anticoagulation environments, and extracorporeal and temporary mechanical circulatory support, these recommendations aim to improve diagnostic accuracy, standardize care, reduce complications, and support safe heparin re-exposure or alternative anticoagulation strategies when surgery is required.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chatterjee S, Girardi NI, Crow J, et al. 2026 American Association for Thoracic Surgery Expert Consensus Document: Diagnosis and management of heparin-induced thrombocytopenia in patients who undergo cardiac surgery. J Thorac Cardiovasc Surg. 2026. PMID: 42092507. doi:10.1016/j.jtcvs.2026.03.619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。